Literature DB >> 816453

Nonsecretory plasma cell dyscrasia followed by acute granulocytic leukemia 25 years after Thorotrast administration.

N C Bethlenfalvay, L B Henley, T D Rupp, R L Phyliky.   

Abstract

Twenty-three years after an injection of Thorotrast, profound depression of humoral and cellular immunity associated with extensive marrow plasmocytosis developed in a man aged 75 years. Twelve months of chemotherapy with L-phenylalanine mustard, resulted in hematologic remission. Radioautograph of his marrow showed signs of alpha-radiation; whole body counting revealed a significant thorium burden. One year after chemotherapy was stopped, and two years after initial presentation, aleukemic acute granulocytic leukemia led to his death. The role of thorium in the etiology of possibly two successive hematopoietic neoplasms is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 816453     DOI: 10.1002/1097-0142(197603)37:3<1449::aid-cncr2820370328>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Thorotrast-associated anemia and bone marrow hypoplasia.

Authors:  D E Summers; E B Chung
Journal:  J Natl Med Assoc       Date:  1986-12       Impact factor: 1.798

2.  Haemangioendothelioma (Kupffer cell angiosarcoma), myelofibrosis, splenic atrophy, and myeloma paraproteinaemia after parenteral thorotrast administration.

Authors:  R C Jennings; S E Priestley
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.